Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT00400556
Eligibility Criteria:
Inclusion Criteria:
* likely to comply with study protocol
* age of 18-70
* histologically proven multiple myeloma or lymphoma
* not currently receiving cytotoxic agents however thalidomide, prednisolone, dexamethasone are allowable
* multiple myeloma patients must be receiving regular bisphosphonates
* absolute neutrophil count between 1.5 and 10.0 x 10\^9/L
* ECOG performance status \</= 3
* life expectancy of at least two months
* written informed consent signed by patient or legally authorised representative
Exclusion Criteria:
* use of other vitamin A preparations within the last 30 days
* active infection or fever \>/= 38.2 degrees celsius
* pregnancy or breast feeding. Women of child bearing potential admitted to the trial must take adequate measures to prevent conception (at least two different forms of contraception) and are to undergo a pregnancy test. Oral contraception must not include low-dose progestogens
* known allergy to E.coli derived products
* current treatment with tetracycline antibiotics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00400556
Study Brief:
Protocol Section:
NCT00400556